Hook & thesis
Pick a side: Nebius or CoreWeave? The market has been rewarding scale and backlog, but it is also punishing companies that can't convert expansion into unit economics. Right now Nebius (NBIS) offers a cleaner line to capture the AI infrastructure upside. It combines explosive top-line growth, emerging profitability signals, and a valuation that - while rich by traditional metrics - is easier to rationalize than CoreWeave's path given Nebius' recent profitability headlines and faster reported revenue expansion.
My trade: lean long Nebius at $210.15 with a hard stop at $182 and a 180-trading-day target of $295. This setup preserves upside toward the $300 range where Nebius found its 52-week high, while limiting downside if market risk aversion or execution problems reappear.
What Nebius does and why the market should care
Nebius Group NV operates an AI-centric cloud platform offering GPU clusters, cloud services and developer tooling geared to generative AI workloads. The company also runs specialized brands across data labeling, edtech re-skilling and autonomous driving research - all ancillary to its core objective: sell GPU compute and software to AI builders worldwide.
The market cares because demand for GPU-based AI compute is massive and time-sensitive. Customers prefer providers who can deploy capacity quickly with end-to-end software that optimizes GPUs for large models. Nebius has positioned itself as a vertically integrated provider that claims both rapid top-line growth and early signs of margin leverage as it scales.
How fast is Nebius growing?
Coverage and reporting in recent weeks point to very large growth prints: several pieces reference Nebius growing roughly 300-500% year-over-year, including a note that cited 351% revenue growth in 2025 and 529% growth in H1 2026. Another article referenced 479% revenue growth in 2025 and even a positive net income figure of $82M in one report. Put simply: growth is not mere double digits; it’s explosive and materially higher than many rivals.
Market snapshot and valuation framing
Nebius trades at $210.15 with a market capitalization of approximately $57.13 billion. Traditional multiples look extreme: a trailing P/E around 794 and a price-to-book near 5.52. At face value those figures are eyebrow-raising; they reflect a company transitioning through very rapid top-line expansion, heavy capex and lumpy free cash flow.
Valuation must therefore be framed as a growth premium play. If Nebius can convert its large customer commitments into productive capacity with the kind of capital efficiency the company is pitching, the current market cap is easier to justify. Compare that conceptually to CoreWeave: it has a very large backlog and scale, but several recent write-ups highlight bigger near-term losses and enormous capex projections ($35-39B for 2026 in one piece), creating a heavier execution and financing burden. That contrast is the basis for preferring Nebius right now.
Technical and market microstructure context
The stock has pulled back from its 52-week high of $299.86 (06/22/2026) to $210.15 today. Short-term technicals show momentum softness: 10-day SMA $231.88, 20-day SMA $229.26 and 50-day SMA $224.81 all sit above the current price; the 9-day EMA is $227.03 and the 21-day EMA $228.25. RSI is in the mid-40s (42.69), which is neither deeply oversold nor bullishly divergent. Institutional/retail short activity has been meaningful: short interest as of 09/30/2026 was ~44.7M shares with days-to-cover around 2.71, and recent daily short volumes show high absolute short activity—this can amplify volatility on both rallies and sell-offs.
Trade plan (actionable)
Here is the exact trade I am taking and why.
| Leg | Detail |
|---|---|
| Direction | Long NBIS |
| Entry | $210.15 (current price) |
| Stop loss | $182.00 |
| Target | $295.00 (180 trading days) |
| Horizon | Long term (180 trading days) - enough time for capacity ramp, customer conversion, and sentiment re-rating |
| Risk level | High |
Rationale: entry at $210.15 captures the post-pullback level with upside back toward the prior $300 range if growth and margin narratives hold. The stop at $182 is below several short-term moving averages and provides a controlled loss if momentum worsens or capital-market conditions tighten. The target of $295 sits just under the 52-week high and is reachable if Nebius executes on capacity and revenue conversion over the next six to nine months.
Catalysts to watch (2-5)
- Quarterly results showing continued 3xx-5xx% revenue growth and improvement or stability in net income/free-cash-flow trends.
- Announcements converting large customer commitments into binding multi-year contracts or capacity reservations - this increases revenue visibility and capital planning comfort.
- Evidence of capital efficiency improvements - lower per-MW build cost, higher throughput per GPU, or favorable partnerships that reduce capital intensity.
- Positive analyst revisions or institutional buying that narrows the gap with peers.
Risks and counterarguments
Every high-conviction growth trade in AI infrastructure carries meaningful execution and macro risk. Key risks here:
- Capital intensity and financing risk - Nebius is scaling GPU farms, which requires significant capital. If credit markets tighten or Nebius' financing costs rise, growth and margins could be impaired.
- Execution risk on capacity conversion - the thesis depends on turning customer commitments into revenue. Delays in data center builds, permitting, supply chain or labor problems could push revenues out and hurt multiples.
- Competition and scale effects - CoreWeave and other large providers have scale advantages. CoreWeave's backlog and capacity roadmap could let it outcompete on price or availability, pressuring Nebius margins.
- Market sentiment and valuation compression - the stock trades at lofty multiples. Any sign of slowing growth, widening losses, or broader risk-off selling could result in rapid and painful multiple contraction.
- Short-squeeze volatility - significant short interest can create sharp intraday moves in either direction, complicating stop management.
Counterargument: CoreWeave's scale and reported backlog ($104B) plus a path toward larger absolute revenues could make it the safer long-term play if it proves it can convert backlog profitably. Recent write-ups note CoreWeave's revenue trajectory toward a larger top-line by 2027 and that it may be closer to sustainable profitability in some scenarios. If markets rotate to favor scale and backlog above growth percentages, CoreWeave could outpace Nebius on returns.
What would change my mind
I would become neutral-to-bearish on this long if one or more of the following happen before my target is hit:
- Quarterly results that show materially slower sequential revenue growth or a sudden re-emergence of significant net losses.
- A financing hiccup or a materially higher capex guide that forces equity dilution or expensive debt raises.
- Clear evidence that CoreWeave (or another competitor) is winning multi-year commitments at materially better economics, implying Nebius will be structurally margin-disadvantaged.
Conclusion
Nebius represents an asymmetric, high-risk/high-reward way to play the AI compute build-out. The company looks to combine very high revenue growth with nascent profitability narratives. Against CoreWeave, the edge today is Nebius' faster reported growth and cleaner near-term profitability message. That does not mean Nebius is cheap or without downside - it is not. Use a defined entry at $210.15, keep the stop at $182, and give the trade time - about 180 trading days - to let capacity, contracts and sentiment converge toward a rerating. If Nebius fails to convert commitment into cash flow or financing dries up, respect the stop and reset the analysis.
Execution note: set orders carefully — given the stock's recent intraday swings and elevated short activity, use limit entries and pre-defined stop orders to avoid emotional decision-making during volatile sessions.
Key data points referenced
- Current price: $210.15
- Market cap: $57,130,378,478
- 52-week range: $73.52 - $299.86
- Trailing P/E: ~794
- Price/Book: ~5.52
- Recent short interest (09/30/2026): ~44.7M shares; days-to-cover ~2.71
- Technical: 10-day SMA $231.88, RSI 42.69